{"acute hepatic failure": 7.22, "acute hepatitis b": 21.08, "acute lung injury": 25.6, "acute myeloid leukaemia": 5.98, "acute respiratory distress syndrome": 3.28, "adenovirus infection": 6.58, "adjustment disorder with depressed mood": 7.5, "agranulocytosis": 4.98, "anaemia": 2.02, "anti-cyclic citrullinated peptide antibody positive": 31.86, "arthritis": 2.1, "arthropathy": 6.77, "aspergillus infection": 6.93, "autoimmune haemolytic anaemia": 5.4, "b-cell lymphoma": 6.58, "b-cell lymphoma recurrent": 70.61, "b-lymphocyte count decreased": 22.87, "back injury": 2.67, "bacteraemia": 7.76, "bacterial infection": 2.57, "bacterial sepsis": 5.44, "basal cell carcinoma": 2.46, "bicytopenia": 11.63, "blepharospasm": 2.65, "blood cholesterol increased": 3.53, "blood lactate dehydrogenase increased": 3.02, "blood pressure diastolic abnormal": 180.75, "blood pressure diastolic decreased": 28.23, "blood pressure diastolic increased": 32.17, "blood pressure fluctuation": 11.64, "blood pressure systolic abnormal": 224.88, "blood pressure systolic increased": 22.5, "body temperature decreased": 6.32, "bone marrow failure": 3.75, "bronchiectasis": 3.56, "bronchopulmonary aspergillosis": 6.0, "bursitis": 6.23, "c-reactive protein abnormal": 7.7, "c-reactive protein increased": 2.76, "candida infection": 2.69, "cardiomyopathy": 2.86, "cardiotoxicity": 3.73, "castleman's disease": 36.33, "cellulitis": 2.01, "central nervous system lymphoma": 31.84, "cerebral disorder": 2.04, "cervix disorder": 22.23, "chronic lymphocytic leukaemia": 22.94, "chronic lymphocytic leukaemia recurrent": 42.28, "clostridium difficile colitis": 2.37, "coeliac disease": 3.57, "contraindicated product administered": 7.05, "covid-19 pneumonia": 9.16, "cytokine release syndrome": 2.28, "cytomegalovirus chorioretinitis": 18.38, "cytomegalovirus infection": 5.98, "cytomegalovirus infection reactivation": 3.83, "cytomegalovirus viraemia": 8.23, "cytopenia": 8.37, "device related infection": 2.07, "diffuse large b-cell lymphoma": 35.82, "diffuse large b-cell lymphoma recurrent": 97.4, "diffuse large b-cell lymphoma refractory": 69.56, "diffuse large b-cell lymphoma stage iv": 69.0, "dilated cardiomyopathy": 2.28, "disease progression": 5.71, "disease recurrence": 2.51, "dislocation of vertebra": 17.76, "disseminated bacillus calmette-guerin infection": 44.86, "drug hypersensitivity": 4.19, "drug intolerance": 4.13, "drug resistance": 2.38, "duodenal ulcer perforation": 32.57, "ear pruritus": 6.61, "ejection fraction decreased": 2.9, "endocarditis": 2.89, "epstein-barr virus infection": 5.06, "eye infection": 2.89, "facet joint syndrome": 17.51, "febrile neutropenia": 19.77, "fibromyalgia": 3.96, "finger deformity": 10.9, "follicular lymphoma": 44.79, "folliculitis": 11.78, "foot deformity": 2.57, "glossodynia": 7.0, "granulocyte count decreased": 17.38, "granulocytopenia": 4.8, "grip strength decreased": 3.54, "haematotoxicity": 8.18, "hand deformity": 16.95, "heart rate decreased": 6.57, "helicobacter infection": 17.85, "hepatic encephalopathy": 2.04, "hepatic enzyme increased": 2.61, "hepatic failure": 2.36, "hepatitis b": 21.51, "hepatitis b reactivation": 108.5, "herpes simplex": 3.41, "hodgkin's disease": 12.61, "humoral immune defect": 254.87, "hypoalbuminaemia": 4.03, "hypogammaglobulinaemia": 30.21, "ill-defined disorder": 6.24, "immune reconstitution inflammatory syndrome": 3.2, "immunodeficiency": 4.58, "immunosuppression": 5.27, "impaired healing": 5.49, "infection": 4.6, "infusion related reaction": 16.4, "intentional product use issue": 3.98, "interstitial lung disease": 7.36, "intestinal perforation": 4.62, "irritable bowel syndrome": 3.56, "jc virus infection": 31.41, "joint range of motion decreased": 2.66, "joint swelling": 3.94, "klebsiella infection": 6.16, "klebsiella sepsis": 16.3, "left ventricular dysfunction": 2.44, "leukopenia": 3.71, "liver injury": 2.69, "localised infection": 2.66, "low birth weight baby": 3.18, "lower respiratory tract infection": 3.76, "lymphocyte count decreased": 6.37, "lymphocytosis": 5.65, "lymphoma": 3.44, "lymphopenia": 5.24, "lymphoproliferative disorder": 7.73, "mantle cell lymphoma": 17.83, "mantle cell lymphoma recurrent": 51.22, "maternal exposure during pregcy": 2.32, "maternal exposure timing unspecified": 3.95, "metastasis": 2.84, "mucosal inflammation": 3.58, "muscle injury": 8.36, "myelodysplastic syndrome": 6.94, "myelosuppression": 13.04, "nasopharyngitis": 2.91, "neutropenia": 7.67, "neutropenic sepsis": 26.02, "neutrophil count decreased": 9.22, "neutrophil count increased": 3.19, "nodule": 3.66, "non-hodgkin's lymphoma": 4.8, "non-hodgkin's lymphoma recurrent": 73.68, "oesophageal candidiasis": 3.95, "off label use": 2.48, "onychomycosis": 7.12, "oxygen saturation decreased": 5.88, "pancytopenia": 5.27, "pemphigus": 9.64, "platelet count decreased": 2.12, "pneumocystis jirovecii pneumonia": 42.37, "pneumonia": 3.24, "pneumonia bacterial": 3.79, "pneumonia cytomegaloviral": 7.73, "pneumonia fungal": 5.1, "poor venous access": 12.53, "post transplant lymphoproliferative disorder": 8.71, "posterior reversible encephalopathy syndrome": 4.23, "premature baby": 2.44, "premature delivery": 2.58, "product use in unapproved indication": 2.6, "productive cough": 2.43, "progressive multifocal leukoencephalopathy": 28.81, "pseudomonas infection": 4.44, "pulmonary alveolar haemorrhage": 2.99, "pulmonary fibrosis": 2.14, "pulmonary toxicity": 15.51, "recurrent cancer": 13.12, "red blood cell sedimentation rate increased": 2.22, "remission not achieved": 215.45, "respiratory failure": 2.55, "respiratory tract infection": 2.05, "rheumatic fever": 13.48, "rheumatoid arthritis": 4.16, "rheumatoid factor positive": 12.33, "richter's syndrome": 52.69, "second primary maligcy": 9.23, "sepsis": 3.58, "septic shock": 4.98, "sinusitis": 2.98, "skin infection": 2.36, "skin laceration": 2.28, "staphylococcal bacteraemia": 5.0, "staphylococcal sepsis": 4.71, "stomatitis": 2.07, "synovitis": 7.75, "systemic lupus erythematosus": 2.17, "temperature regulation disorder": 2.18, "therapeutic product effect decreased": 2.11, "therapeutic response decreased": 2.21, "therapy non-responder": 3.14, "therapy partial responder": 13.06, "thrombocytopenia": 2.91, "tooth disorder": 2.33, "tooth infection": 5.67, "traumatic lung injury": 7.82, "treatment failure": 3.57, "tumour lysis syndrome": 23.85, "upper respiratory tract infection": 2.21, "urosepsis": 2.43, "varicella zoster virus infection": 5.83, "white blood cell count decreased": 7.27, "wound": 2.73}